MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4103/0973-1482.168996

Медицинская библиотека · Journal of cancer research and therapeutics · 2015

Experience of bevacizumab in a patient with colorectal cancer after renal transplantation.

Müsri Fatma Yalcin, Mutlu Hasan, Eryılmaz Melek Karakurt, Salim Derya Kıvrak, Coşkun Hasan Şenol

Клинический случайПисьмо в редакциюПеревод пока не подготовлен

Аннотация

Bevacizumab is a drug that is widely used for the first-line treatment of metastatic colorectal cancer (mCRC). Bevacizumab neutralizes vascular endothelial growth factor and can lead to proteinuria and renal damage. In this case, experience on full dose short-time treatment of bevacizumab in a patient under immunosuppressive treatment for renal transplantation with chronic renal failure has been shared. The patients were diagnosed with mCRC 7 months ago. The patient had multiple liver metastases at the time of the diagnosis. He had a history of renal transplantation 2 years ago because of renal failure, and he had been under immunosuppressive treatment for this reason. 5-fluorouracil-leucovorin-irinotecan -bevacizumab regimen was begun for the treatment of mCRC. The dose of bevacizumab was 5 mg/kg/day for 14 days. There was 2.5 g/day of proteinuria at the start of the treatment. However, renal dysfunction progressed, and proteinuria increased to 4 g/day in the 3rd month of treatment. In this case, the experience of using bevacizumab in a patient under immunosuppressive treatment for renal transplantation with chronic failure has been presented.

Для цитирования: Müsri Fatma Yalcin, Mutlu Hasan, Eryılmaz Melek Karakurt, Salim Derya Kıvrak, Coşkun Hasan Şenol. Experience of bevacizumab in a patient with colorectal cancer after renal transplantation.. Journal of cancer research and therapeutics. 2015. DOI: 10.4103/0973-1482.168996.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.